The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample

Increase of myeloid microvesicles in the cerebrospinal fluid as biomarkers of microglia/microphage activation in neurological disorders

MATTEOLI, MICHELA;FURLAN, Raffaello
2011

Abstract

The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/55563
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact